A study on prescribing pattern of antihypertensives in adult patients attending in a tertiary care hospital of Assam, India
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20161555Keywords:
Drug utilisation, Prescription pattern, Antihypertensive drugs, JNC 8Abstract
Background: Hypertension is one of the most common chronic medical problems prompting visits to health care providers. It has been estimated that hypertension accounts for 13% of deaths worldwide. The main objective of the present study was to assess the pattern of drug utilisation and to evaluate whether the prescribing patterns for anti-hypertensive in our institution is in adherence with JNC 8 guidelines for treatment of hypertension.
Methods: A prospective, observational, non-interventional, hospital based study was carried out for the period of three months in an out-patient department. Adult patients of either sex who have been diagnosed with hypertension as per JNC-8 guidelines without co morbidities and patients receiving or prescribed with antihypertensive drugs were included. The analysis of the prescription frequency, proportion of the different antihypertensive classes of drugs as monotherapy as well as combination therapy was done.
Results: The most common drug classes involved in the study was angiotension II receptor antagonists followed by calcium channel blocker. The most common anti-hypertensive fixed dose combination therapy involved in the study was angiotensin II receptor antagonist+thiazide diuretic. 67% of the cases received monotherapy whereas remaining 33% received combination therapy.
Conclusions: Our study shows that the most commonly prescribed drug classes involved were angiotensin II receptor antagonists followed by calcium channel blocker and the anti-hypertensive drug combinations among hypertensive patients were considerable and this practice positively impacted on the overall blood pressure control.
References
Collins R, Peto R, Mac MS, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease. Part 2.Short-term reductions in blood pressure: overview of randomised drug trial in their epidemiological context.Lancet. 1990;335:827-38.
Hansson L. The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension. J Hypertens. 1996;14:537-44.
Guilbert, JJ. The world health report 2002: Reducing risks, promoting healthy life. Educ Health. 2003;16:230.
Hansson L, Dahlof B, Gudbrandsson T, Hellsing T, Kullman S, Kuylenstierna J, et al. Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy. J Cardiovasc Pharmacol. 1988;12:94-101.
Kjeldsen SE, Farsang C, Sleigh P, Mancia G, World Health Organization; International society of hypertension. 1999 WHO/ISH hypertension guidelines-highlights and esh update. J Hypertens. 2001;19:2285-8.
Ramsay LE. British hypertension society guideline for hypertension management: summary. Br Med J. 1999;319:630-5.
Kapoor B, Raina RK, Kapoor S. Drug prescribing pattern in a teaching hospital. Ind J Pharmacol. 1985;17(1):168.
Pradhan SC, Shewade DG, Shashindran CH, Bapna JS. Drug utilization studies. National Med J India. 1988;1:185.
Bimo, Chowdhary A, Das A, Diwan V, Kafle KK, Mabadeje B, et al. In: how to investigate drug use in health facilities (selected drug use indicator) action programme on essential drugs. WHO official publication. 1995:68.
Yuen YH, Chang S, Chong CK, Lee SC, Critchlev JA, Chan JC. Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther. 1998;23:287-94.
Jhaj R, Goel NK, Gautam CS, Hota D, Sangeeta B. Prescribing patterns and cost of antihypertensive drugs in an internal medicine clinic. Ind Heart J. 2001;53:323-27.
Mancia G, Grassi G. Antihypertensive treatment: past, present and future. J Hypertens. 1998;16:1-7.
Prisant LM, Beall SP, Nicholads GE, Feldman EB, Carr AA, Feldman DS, et al. Biochemical, endocrine, and mineral effects of indapamide in black women. J Clin Pharmacol. 1990;30:121-6.
